Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Treatment of cardiac arrhythmias during pregnancy. Safety considerations
Jose A. Joglar
, Richard L. Page
Internal Medicine
Cardiology
Research output
:
Contribution to journal
›
Article
›
peer-review
109
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of cardiac arrhythmias during pregnancy. Safety considerations'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Cardiac Arrhythmias
61%
Anti-Arrhythmia Agents
46%
Pregnancy
43%
Safety
42%
Mothers
30%
First Pregnancy Trimester
24%
Supraventricular Tachycardia
20%
Lidocaine
16%
Fetus
12%
Therapeutics
11%
Flecainide
11%
Procainamide
11%
Torsades de Pointes
10%
Quinidine
10%
Electric Countershock
10%
Amiodarone
9%
Digoxin
9%
Drug Therapy
9%
Implantable Defibrillators
9%
Phenytoin
9%
Fetal Growth Retardation
8%
Local Anesthetics
8%
Adenosine
7%
Tachycardia
7%
Conservative Treatment
7%
Pharmaceutical Preparations
6%
Edema
6%
Hemodynamics
5%
Observation
5%
Serum
3%
Chemical Compounds
Antiarrhythmic Agent
100%
Safety
61%
Flecainide
18%
Intrauterine
16%
Amiodarone
16%
Drug
16%
Procainamide
16%
Hemodynamic
15%
Digoxin
14%
Quinidine
14%
Phenytoin
13%
Lidocaine
13%
Local Anaesthetic
13%
Adenosine
9%